Check out their delicious hot sauce!
The U.S. Food and Drug Administration (FDA) has issued a warning to healthcare professionals to avoid using unapproved epinephrine nasal solutions produced by BPI Labs LLC and Endo USA. The agency highlighted the potential for confusion between these nasal solutions and FDA-approved injectable epinephrine products, leading to medical errors.
Continues after this brief message…
Did you know? Paid supporters get a reduced ad experience!
We know you value local news and entertainment that is free, open, and independent. Producing high-quality, paywall-free content isn't free. It takes time, effort, and resources to keep you informed and entertained. Unlike corporate media, we don’t have deep-pocketed investors or big advertisers funding our work—we rely on you, our readers and listeners, to keep Radio Free Hub City running. We're literally running on a shoe-string budget, but keep working hard to provide as much news and entertainment as we can.
If just 5% of local area residents became paid supporters at only $5 per month, we could meet our fundraising goals and continue expanding our news coverage depth while continuing to provide free access for everyone. So, if you'd like to help us in our continuing quest to improve our coverage, please consider becoming a paying supporter.
Will you be one of the 5%?
Thank you for supporting Radio Free Hub City!
The unapproved nasal solutions, packaged similarly to their injectable counterparts, have been mistakenly administered intravenously. Such errors are significant because nasal solutions are not required to be sterile, unlike injectable medications. Administering a non-sterile product intravenously increases the risk of severe infections, which can pose life-threatening risks to patients.
Despite these risks, BPI Labs has not complied with FDA recommendations to recall its unapproved nasal solution, even after repeated follow-ups. Conversely, Endo USA voluntarily recalled its unapproved nasal solution in December 2024 to prevent further incidents.
Alerts
We Need Your Support Now More Than Ever, Will You Contribute $5 Per Month?
For five years we’ve spent a lot of time giving away our news, for free. And with all things, “free” has a cost, and that cost has now come due. Without reader support, Radio Free Hub City cannot survive long-term.…
Article continues after these messages…
We didn't pick our name by accident. While other outlets are proud to be government 'Partners,' we are proud to be exactly what our namesake requires: Free from government influence, and free from government censorship. We don't lock our news behind a paywall, will you help us keep it that way? If you're tired of news sweetened with confirmation bias that never questions the 'official story', consider becoming a monthly supporter. Just $5/month helps fund our local reporting, live election night coverage, and more.
Since 2016, the FDA has received more than 25 reports of confusion involving these products due to similarities in labeling and packaging. A recent incident in 2024 involved a patient receiving the nasal solution intravenously, underscoring the ongoing dangers of these look-alike products in clinical settings. The FDA continues to urge healthcare professionals to ensure they are using approved products to avoid such mistakes.
Article by multiple RFHC contributors.
Do you believe we got something wrong? Please read our publishing standards and corrections policy.
Video Spotlight
Did you know? Supporters get a reduced ad experience!
Sponsored Articles
Get daily and breaking news for Washington County, MD area from Radio Free Hub City. Sign up with your email today!
Paid supporters have a reduced ad experience!
Discover more from Radio Free Hub City
Subscribe to get the latest posts sent to your email.